Acute coronary syndrome (NSTEMI)
AHA/ACC NSTEMI- Troponin I 0.18 ng/mL (elevated above 0.04 threshold)
- ST depression in V4–V6 on ECG
- TIMI risk score: 4 (intermediate)
Decision support. Each mockup below is illustrative of product UI. The system surfaces; you evaluate and sign. ChironAI does not make a regulatory clearance claim; see Disclosures.
One clinic day, top to bottom. The schedule has eighteen patients on it. The previous doctor on the rotation said the system had her back; you take her word for it and you log in.
The patient completed a structured intake on the portal yesterday afternoon. Chief complaint, history of present illness, ROS, social context, red-flag triggers. By the time you open the chart, the answers you would have spent five minutes asking are already in there. The risk flags are surfaced at the top.
You read for thirty seconds. You walk in knowing the question.
Chief complaint. Recurring headaches over the last 3 weeks.
Surfaced for clinician attention
What this changes
You took the history. You did the exam. You have a working impression. You also have ChironAI showing you the differential it would consider, ranked by Bayesian confidence, with the discriminating features called out per candidate. Your impression is already in the top three. You see what you missed in the others.
You decide. The system documents what you decided.
Must review before final
Decision-support output. Clinician review and attestation required before this content is signed into the chart.
Presentation. 54-year-old male with acute substernal chest pain radiating to left arm, 2-hour duration, diaphoretic.
You ordered the imaging. The radiologist drafts and signs the impression of record. ChironAI ran a structured second-look on the same study, surfaced candidate findings the fast read might miss, classified the case under the appropriate framework, and routed the time-critical finding through a separate Red-Alert path so it could not be buried.
When the radiologist’s signed read lands in your inbox, the candidate Red- Alert finding is at the top. Not paragraph three.
Must review before final
Decision-support output. Clinician review and attestation required before this content is signed into the chart.
Red-Alert findings
Time-critical. Surface to the supervising clinician for action.
Candidate impression — for radiologist review
Spiral oblique fracture of the right tibial diaphysis at the mid-shaft, with mild lateral displacement and angulation. Associated comminuted fragment laterally. Fibular shaft intact.
A single TSH out of range is data. The same patient’s last six TSH values trending upward across fourteen months is a pattern. ChironAI reasons across the trajectory, recognizes the pattern, and surfaces the recommendation with the guideline anchor that warrants it.
You order the reflex testing. You decide whether to initiate therapy. The system documents what you ordered and why.
Must review before final
Decision-support output. Clinician review and attestation required before this content is signed into the chart.
Pattern recognized — Subclinical hypothyroidism progressing
TSH trending upward over the last 14 months (3.2 → 4.8 → 5.9 → 7.1 mIU/L). Free T4 remains in normal range. Pattern consistent with subclinical hypothyroidism with increasing biochemical severity.
Repeat TSH + free T4 in 4–6 weeks. Discuss patient symptoms; if symptomatic or TSH > 10 mIU/L, consider levothyroxine initiation.
TSH (mIU/L) — last 14 months
Every SOAP note in your queue is drafted from the consultation context. Every statement in the assessment links back to the source field that produced it — click a sentence, see the chart row that justifies it. You read, edit, sign.
The patient with the migraine workup needed her instructions in Spanish at a middle-school reading level. The system rendered it. You signed. You went home.
Must review before final
Decision-support output. Clinician review and attestation required before this content is signed into the chart.
Subjective
58-year-old female with type 2 diabetes returns for routine follow-up. Reports adherence to metformin 1000 mg BID. Self-monitored fasting glucoses 140–180 mg/dL. No hypoglycemic episodes. No polyuria, no visual changes. Diet adherence intermittent; exercise sporadic.
Assessment — source-grounded
A1c 7.8% — above target (< 7.0% for this patient profile per ADA Standards of Care 2026). (source: Lab: HbA1c 7.8%, 2026-04-22)
eGFR 78 mL/min/1.73m² with no microalbuminuria — stable kidney function, supportive of intensified glucose-lowering therapy. (source: Lab: eGFR 78 / UACR < 30, 2026-04-22)
We do live walkthroughs with practicing physicians on real (de-identified) cases. The best way to evaluate ChironAI is to bring a case you saw last week and see how the system would have surfaced it.